What is the best treatment for a 10-year-old with tinea cruris on the buttocks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Tinea Cruris on the Buttocks in a 10-Year-Old

Apply a topical antifungal cream once daily for two weeks as first-line treatment for this localized tinea cruris infection.

First-Line Treatment Approach

  • Topical antifungal therapy is the appropriate first-line treatment for tinea corporis and tinea cruris in children with localized disease, reserving oral therapy only for extensive infections, treatment failures, or immunocompromised patients 1.

  • The FDA-approved econazole nitrate cream 1% should be applied once daily to cover the affected areas on the buttocks for two weeks to reduce the possibility of recurrence 2.

  • Alternative topical options include allylamine antifungals (terbinafine or naftifine) or other azole antifungals (clotrimazole, miconazole, ketoconazole), all of which have demonstrated efficacy in pediatric tinea infections 3, 4.

Treatment Duration and Monitoring

  • Complete the full two-week course of topical therapy even if clinical improvement occurs earlier, as early symptom relief does not indicate mycological cure 2.

  • If no clinical improvement is seen after the two-week treatment period, the diagnosis should be reconsidered and mycological confirmation obtained through potassium hydroxide preparation or fungal culture 2, 5.

  • The definitive treatment endpoint should be mycological cure, not just clinical response, with follow-up assessment recommended until clearance is documented 1, 6.

When to Consider Oral Therapy

  • Oral antifungal therapy becomes necessary when the infection is resistant to topical treatment, involves extensive areas, shows maceration with secondary infection, or occurs in immunocompromised individuals 7, 5.

  • For children requiring oral therapy, itraconazole 100 mg daily for 15 days (87% mycological cure rate) or terbinafine 250 mg daily for 1-2 weeks are effective options, though dosing adjustments are needed for younger/smaller children 7.

  • Note that itraconazole is licensed for children over 12 years in the UK and has important drug interactions to consider 7.

Prevention and Recurrence Management

  • Implement preventive measures including keeping the skin dry and cool, avoiding sharing towels and personal items, covering lesions, and properly cleaning contaminated items 7, 6.

  • Screen and treat family members if the infection is caused by anthropophilic species like Trichophyton tonsurans, as over 50% of household contacts may be affected 1, 7.

  • Clean all fomites (towels, clothing) with disinfectant or 2% sodium hypochlorite solution to prevent reinfection 1, 7.

Important Clinical Caveats

  • Predisposing factors in adolescents include heat, humidity, hyperhidrosis (common in athletes), obesity, and diabetes mellitus 8.

  • Accurate diagnosis ideally should be confirmed through potassium hydroxide preparation or fungal culture before initiating treatment, though treatment can be started immediately when clinical features strongly suggest tinea 6, 5.

  • Topical terbinafine 1% cream applied once daily for one week has shown 92% effectiveness in pediatric tinea corporis and cruris with excellent tolerability 3.

References

Guideline

First-Line Treatment for Tinea Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

What is the best way to treat tinea cruris?

The Journal of family practice, 2006

Guideline

Treatment of Tinea Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Tinea Corporis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tinea cruris in children.

Cutis, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.